Shikhar Mehrotra to Neovascularization, Pathologic
This is a "connection" page, showing publications Shikhar Mehrotra has written about Neovascularization, Pathologic.
Connection Strength
0.211
-
Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Ann Surg Oncol. 2019 Dec; 26(13):4782-4790.
Score: 0.162
-
HuR as a molecular target for cancer therapeutics and immune-related disorders. Adv Drug Deliv Rev. 2022 09; 188:114442.
Score: 0.049